Market Research Report
Asia Pacific Implantable Cardiac Monitors Market Analysis (2017-2023)
|Published by||KBV Research||Product code||644795|
|Published||Content info||61 Pages
Delivery time: 1-2 business days
|Asia Pacific Implantable Cardiac Monitors Market Analysis (2017-2023)|
|Published:||Content info: 61 Pages||
This publication has been discontinued on August 13, 2018.
The Asia Pacific Implantable Cardiac Monitors Market would witness market growth of 8.9% CAGR during the forecast period (2017 - 2023).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device.
The implantable cardiac monitors market is witnessing moderated growth owing to the technological advancements in cardiac monitor devices, amplifying demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation. Additionally, Favorable reimbursement policies and prominent market players operating in the region are the factors that are further supporting the implantable cardiac monitor market growth.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Implantable Cardiac Monitors market segments the market into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the Asia Pacific Implantable Cardiac Monitors Market. Key companies profiled in the report include Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma inc., Thoratec Corporation St.(Jude Medical, LLC), Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.